We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$3.02B
AUM Growth
+$434M
Cap. Flow
+$190M
Cap. Flow %
6.3%
Top 10 Hldgs %
45.02%
Holding
338
New
35
Increased
173
Reduced
106
Closed
7
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
26
Charles Schwab
SCHW
$181B
$23.9M 0.79%
347,622
+4,190
+1% +$242K
INTC icon
27
Intel
INTC
$460B
$23.7M 0.78%
471,405
-1,997
-0.4% -$81.1K
PAYX icon
28
Paychex
PAYX
$41.4B
$22.5M 0.75%
188,951
+5,142
+3% +$609K
ACN icon
29
Accenture
ACN
$99.9B
$22.2M 0.74%
63,292
+1,823
+3% +$588K
META icon
30
Meta Platforms (Facebook)
META
$1.37T
$21.3M 0.7%
60,074
+333
+0.6% +$108K
AMZN icon
31
Amazon
AMZN
$2.53T
$21.1M 0.7%
138,550
-332
-0.2% -$46.5K
CVS icon
32
CVS Health
CVS
$134B
$20.2M 0.67%
255,829
+7,344
+3% +$523K
AMD icon
33
Advanced Micro Devices
AMD
$791B
$20.2M 0.67%
136,764
+82
+0.1% +$9.66K
RHI icon
34
Robert Half
RHI
$3.81B
$19.1M 0.63%
216,808
+5,519
+3% +$439K
QCOM icon
35
Qualcomm
QCOM
$159B
$18.9M 0.62%
130,351
+2,737
+2% +$339K
RTX icon
36
RTX Corp
RTX
$289B
$18.4M 0.61%
218,337
+7,821
+4% +$619K
UPS icon
37
United Parcel Service
UPS
$89.5B
$18M 0.59%
114,232
+5,489
+5% +$830K
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$17.7M 0.59%
344,964
+13,524
+4% +$710K
DOCU
39
DocuSign
DOCU
$10.4B
$17.3M 0.57%
291,500
+4,669
+2% +$214K
V icon
40
Visa
V
$684B
$16.9M 0.56%
64,995
+1,099
+2% +$271K
EXPE icon
41
Expedia Group
EXPE
$35.2B
$16.9M 0.56%
111,362
+2,401
+2% +$294K
EOG icon
42
EOG Resources
EOG
$77.5B
$16M 0.53%
132,506
+4,625
+4% +$576K
AMAT icon
43
Applied Materials
AMAT
$398B
$15.7M 0.52%
96,997
+662
+0.7% +$97.3K
LULU icon
44
lululemon athletica
LULU
$13.6B
$15.7M 0.52%
30,633
-359
-1% -$155K
VCR icon
45
Vanguard Consumer Discretionary ETF
VCR
$5.98B
$15.6M 0.52%
+51,098
New +$14.2M
JPM icon
46
JPMorgan Chase
JPM
$933B
$15.5M 0.51%
91,243
+2,621
+3% +$397K
MDT icon
47
Medtronic
MDT
$110B
$15.4M 0.51%
187,049
+9,223
+5% +$703K
ABBV icon
48
AbbVie
ABBV
$455B
$15.4M 0.51%
99,361
+4,251
+4% +$620K
A icon
49
Agilent Technologies
A
$39.2B
$15.2M 0.5%
109,073
+1,812
+2% +$216K
JNJ icon
50
Johnson & Johnson
JNJ
$617B
$15M 0.5%
95,715
+2,544
+3% +$390K

Similar funds

Grimes & Company's Q4 2023 Portfolio in Review

As of Q4 2023, Grimes & Company held 338 positions worth $3.02B, up 17% from $2.59B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $190M of net new capital in Q4 2023, opening 35 new positions and adding to 173 existing holdings. Its largest new stake was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $163M trimmed.

  • Grimes & Company's largest Q4 2023 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 3,933,072 shares worth $166M.
  • Grimes & Company added most to iShares Core MSCI Emerging Markets ETF in Q4 2023, an estimated $83M increase.
  • Grimes & Company's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $163M.
  • Grimes & Company fully exited State Street Financial Select Sector SPDR ETF in Q4 2023, selling an estimated $11.8M.
  • Grimes & Company's ten largest holdings make up 45% of its $3.02B portfolio in Q4 2023.
  • Grimes & Company opened 35 new positions and closed 7 in Q4 2023.
  • Grimes & Company's portfolio value rose 17% quarter-over-quarter to $3.02B.

Based on Grimes & Company's 13F filing for Q4 2023, filed 24 Jan 2024.